Analysts at StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAII – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “buy” rating on the stock.
Natural Alternatives International Stock Performance
NASDAQ:NAII opened at $4.56 on Tuesday. The company has a fifty day moving average of $4.87 and a 200-day moving average of $5.62. The firm has a market capitalization of $28.27 million, a P/E ratio of -2.98 and a beta of 0.58. The company has a quick ratio of 1.50, a current ratio of 2.56 and a debt-to-equity ratio of 0.11. Natural Alternatives International has a twelve month low of $4.11 and a twelve month high of $7.37.
Natural Alternatives International (NASDAQ:NAII – Get Free Report) last announced its quarterly earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. The business had revenue of $29.49 million for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%.
Institutional Trading of Natural Alternatives International
About Natural Alternatives International
Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
Recommended Stories
- Five stocks we like better than Natural Alternatives International
- The 3 Best Fintech Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Some of the Best Large-Cap Stocks to Buy?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.